The President's Emergency Plan for AIDS Relief has provided life-saving treatment to tens of millions since it was established in 2003

The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via

A legally contested executive order on foreign aid did, at least initially, halt the distribution of life-saving HIV drugs.

JOHANNESBURG - More than 15,000 health workers in the country will be affected by the Trump administration’s decision to withdraw HIV/AIDS relief. Earlier this week, US President Donald Trump announced a freeze on the President’s Emergency Plan for AIDS Relief (PEPFAR).

The Trump administration on January 24 halted disbursement of funds to programmes to treat HIV, malaria and other diseases in developing countries for at least 90 days.

"If at all there may be funding challenge, the Company reasonably believes it will not affect the procurement of medications," said Laurus Labs.

A new report estimates that 135,987 babies will be born with HIV during the 90-day stoppage on foreign aid spending.

“Since its bipartisan creation, PEPFAR has always been synonymous with saving lives and this waiver restores – in some part – that legacy. However, PEPFAR’s continued and uninterrupted support of all HIV treatment and prevention services must be fully restored,” IAS President Beatriz Grinsztejn said.

National Agency for the Control of AIDs (NACA) has commended the U.S. government for issuing emergency waiver to ensure that millions

On Wednesday, US Secretary of State Marco Rubio allowed the continued distribution of HIV medications in the 55 countries supported by the US President’s Emergency Plan for Aids Relief. However, it remains unclear whether the waiver includes preventive drugs or other critical services.